Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

ALKEM ☆ NSE also on BSE

ALKEM LABORATORIES LTD. · code 11703 · INE540L01014 · Pharma & Healthcare · series EQ · Daily price history

5,145.00 -77.50 (-1.48%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
40

ISA Signal Score: Weak

Caution: avoid adding, review holdings. Based on prices to 2026-11-19. Confidence 100%.

Trend0
Momentum38
52-week range21
Volume29
Risk83
Fundamentals71

Working for it

  • Revenue grew 13% year on year
  • Low debt

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • Price is below its 200-day average (long-term weakness)
  • 50-day average is below the 200-day average
  • MACD is negative and weakening
  • More volume on down days than up days (distribution)

Measured reference levels (not forecasts): 20-day low 4,947.00, 52-week high 5,890.00, typical daily move 138.21, two typical moves below price 4,868.57.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityStrongROE 18.2%, ROCE 20.7%, debt 0.15x equity
GrowthSteadySales 8.5%, profit 8.8% a year over 4 years
ValuationCheapP/E 26.7 vs sector median 42.8
MomentumWeakBelow its 200-day average, lagged NIFTY 50 by 8.0 points
RiskLowSwings 23% a year, fell up to 16% from a peak, beta 0.66

Smart Investor Tips: ALKEM

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • High capital efficiency: ROE of 18.2% indicates strong returns on shareholder equity.
  • Attractive relative valuation: P/E of 26.7x is at a discount to the sector median of 42.8x.
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • Long-term downtrend: price is below its 200-day average (Rs 5,408.96). Wait for a base formation and reclaim of the 50-day average (Rs 5,200.72) before committing fresh capital.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceHOLD / POSITIVE ON SUPPORT (Score 49/100)

Consolidating. If buying, accumulate only on dips into support at Rs 4,811.00 – Rs 5,145.00 (Ideal ~Rs 4,978.00). Review if price closes below Rs 4,603.68; upside resistance near Rs 5,651.78.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 4,811.00 – Rs 5,145.00
Ideal ~Rs 4,978.00
Rs 5,145.00 Rs 4,811.00 Rs 4,603.68
ATR 2.7%
Rs 5,651.78 Rs 6,100.96 1 : 1.8
RSI 53 · Vol 0.66x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change -5.9% · high 5,882.50 · low 4,811.00 · max drawdown -14.9%

Live Candlestick & TradingView Chart (ALKEM)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 19 Nov

P/E26.7sector median 42.8
P/B-price / book value
EPSRs 192.51grew 8.8% a year
Dividend yield-from saved dividend events
Debt to equity0.15xnet debt Rs 2,047 Cr
Sales growth8.5%a year over 4 years
Profit growth8.8%a year over 4 years
Operating margin20.4%net margin 16.0%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 3.05. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Strong Balance Sheet & Cash Flow · Score 87/100
Total Debt / Loans Rs 2,047 Cr Increased +Rs 666 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 2,047 Cr 9.8% of total assets
Debt to Equity & Interest Cover 0.15x D/E Interest cover: 18.8x EBIT
Operating Cash Flow (OCF) Rs 1,963 Cr OCF/PAT conversion: 83%
Free Cash Flow (FCF) - OCF minus Capex
  • Low Debt-to-Equity (0.15x).
  • Strong loan interest coverage (18.8x EBIT/Interest).
  • High earnings quality: Operating Cash Flow converts 95% of net profit into real cash.

About ALKEM LABORATORIES

Pharma & Healthcare

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed23 Dec 2015BSE not available · NSE 23 Dec 2015
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness3 of 8Missing: description, share count, book value, ROE, ROCE

Checked: NSE 19 Nov 2026, NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 49.70% 0.00 pp, public 50.30%, as on 30 Sep 2026. Holder names and history

Day range5,115.00 to 5,233.50Open 5,220.00
52-week high5,933.50 -13.3% from high (13 Jan 2026)
52-week low4,811.00 +6.9% from low (22 Oct 2026)
Volume2.44 L 1.5x the 20-day average
RSI (14)47 neutral
Volatility (30d)21.9%annualised
4,811.00
5,933.50

Returns

1W-3.0%
1M+2.8%
3M-4.7%
6M-6.5%
1Y-10.1%
YTD-6.6%
3Y a year+5.0%
5Y a year+8.1%

Against the NIFTY 50

PeriodALKEMNIFTY 50Difference
1M+2.8%+11.5% -8.7 pts
3M-4.7%+5.3% -10.0 pts
6M-6.5%+7.9% -14.3 pts
1Y-10.1%-2.1% -8.0 pts

Risk over the past year

Volatility23%low
Deepest fall-16.0%from a peak
Beta0.66moves less than the index
Best day+3.9%15 Apr 2026
Worst day-8.0%13 Feb 2026
Up days49%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 6 / 9 · Solid Financial Health
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 16.0% × Asset Turnover: 0.71x × Equity Multiplier: 1.51x = ROE 18.2%
✓ Positive Net Profit (PAT > 0) Rs 2,351 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 1,963 Cr
⚠ High Cash Conversion (OCF >= 85% of PAT) 83% conversion
⚠ Improving Return on Assets (ROA YoY) 11.3% vs 12.5%
✓ Conservative / Decreasing Debt-to-Equity 0.15x (prev 0.12x)
✓ Healthy Balance Sheet Asset Coverage 4.18x
✓ Institutional Return on Equity (ROE >= 14%) 18.2%
⚠ Stable / Expanding Profit Margin YoY 16.0% vs 17.1%
✓ Asset Turnover Efficiency (Sales / Assets) 0.71x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 2,2873,1443,3714,0013,7373,6033,7404,552
Sales QoQ % -20.4%+37.5%+7.2%+18.7%-6.6%-3.6%+3.8%+21.7%
Operating Profit 6583907409218285187661,026
Operating Margin (OPM %) 28.8%12.4%22.0%23.0%22.2%14.4%20.5%22.5%
Net Profit (PAT) 723322668779653251521667
Profit QoQ % +3.7%-55.5%+107.5%+16.6%-16.2%-61.6%+107.6%+28.0%
Profit YoY % +43.4%-0.9%+14.5%+11.7%-9.7%-22.0%-22.0%-14.4%
Net Margin % 31.6%10.2%19.8%19.5%17.5%7.0%13.9%14.7%

Sales and profit Rs crore, consolidated

Sales growth+8.5%a year, 4Y
Profit growth+8.8%a year, 4Y
EPS growth+8.8%a year, 4Y
Avg ROE17.4%5 years

Profit and loss

Rs croreFY22FY23FY24FY25FY26
Sales10,63411,59912,66812,96514,712
Sales growth-+9.1%+9.2%+2.3%+13.5%
Operating profit2,0541,5062,1242,5123,007
Operating margin19.3%13.0%16.8%19.4%20.4%
Other income146216311494407
Interest52.0107112122161
Depreciation304310299357382
Profit before tax1,8441,3052,0232,5272,871
Tax rate9.0%22.8%10.5%12.0%18.0%
Net profit1,6809841,7962,2152,351
Profit growth--41.4%+82.5%+23.3%+6.1%
Net margin15.8%8.5%14.2%17.1%16.0%
EPS (Rs)137.6382.31150.19181.11192.51

Balance sheet

Rs croreFY22FY23FY24FY25FY26
Equity (net worth)8,6389,04510,31211,98513,820
Borrowings2,6681,3971,2141,3812,047
Cash-2,6171,579--
Total assets14,06913,75715,57517,69120,858
Debt to equity0.31x0.15x0.12x0.12x0.15x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY22FY23FY24FY25FY26
Operating Cash Flow (OCF)1,1111,6831,9481,9131,963
Capital Expenditure (Capex)-233259--
Free Cash Flow (FCF = OCF - Capex)-1,4501,689--
OCF / Net Profit Conversion0.66x1.71x1.08x0.86x0.83x
Total Borrowings / Loans2,6681,3971,2141,3812,047
Cash & Bank Balances-2,6171,579--
Trade Receivables (Cr)-2,1322,253--
Receivable Days-67.09x64.91x--
Inventories (Cr)-2,6082,661--
Inventory Days-82.05x76.68x--

Returns on capital

Rs croreFY22FY23FY24FY25FY26
ROE19.4%11.1%18.6%19.9%18.2%
ROCE16.8%13.2%19.7%21.2%20.7%
Interest cover36.46x13.15x19.00x21.71x18.83x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LTD 1,449.90 +0.4% - 17,769 37.7 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LAB LTD. 2,084.60 -0.0% - 15,833 34.6 6.8 19.7% 27.0%
AARTIPHARMAARTI PHARMALABS LIMITED 1,024.60 +1.1% - 9,285 42.8 5.3 12.3% 11.7%
BLUEJETBLUE JET HEALTHCARE LTD 516.85 -0.3% - 8,965 54.8 10.6 19.4% 23.0%
AARTIDRUGSAARTI DRUGS LTD. 498.90 -1.4% - 4,587 26.9 3.6 13.4% 6.8%
DIVISLABDIVI S LABORATORIES LTD 11,178.00 +1.2% - - 115.6 - 15.3% 24.3%
WOCKPHARMAWOCKHARDT LIMITED 2,187.00 +7.9% - - - - - -
LAURUSLABSLAURUS LABS LIMITED 2,306.00 -0.7% - - - - - -
SUNPHARMASUN PHARMACEUTICAL IND L 1,900.00 +1.5% - - - - - -
MAXHEALTHMAX HEALTHCARE INS LTD 1,040.65 +1.7% - - - - - -
CIPLACIPLA LTD 1,418.50 +0.1% - - 29.5 - - 13.7%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L 8,738.00 -0.9% - - 64.7 - 21.1% 7.9%
ALKEMALKEM LABORATORIES LTD. 5,145.00 -1.5% - - 26.7 - 17.0% 16.0%
Sector median- 42.86.813.4%

The 13 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is below its 200-day average (long-term downtrend) RSI 47: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower half of its 1-year range and is lower than it was on 93% of days in the past year.

Support (prices below today's)

20-day low4,811.00-6.5%
60-day low4,811.00-6.5%
52-week low4,811.00-6.5%

Resistance (prices above today's)

50-day average5,200.72+1.1%
200-day average5,408.96+5.1%
20-day high5,475.00+6.4%
60-day high5,475.00+6.4%

Zones buyers often watch

Lower quarter of the 1-year range 4,811.00 to 5,091.63 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 4,746.80 to 5,340.15 price is inside this zone now
Around the 200-day average 5,246.69 to 5,571.23 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -16.0%. Currently -12.6% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average5,168.33 Price is 0.5% below
50-day average5,200.72 Price is 1.1% below
200-day average5,408.96 Price is 4.9% below
RSI (14)47Neutral
MACD (12, 26, 9)3.95Below its signal line (momentum fading)
Volatility (30d)21.9%Low yearly swings

Support and resistance

R25,283.00
R15,214.00
Pivot5,164.50
S15,095.50
S25,046.00

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 5,220.00 5,233.50 5,115.00 5,145.00 -1.48% 243,631
2026-11-18 5,195.00 5,236.00 5,150.00 5,222.50 +0.92% 82,227
2026-11-17 5,144.50 5,259.00 5,144.50 5,175.00 +0.76% 124,946
2026-11-16 5,115.00 5,186.50 5,096.00 5,136.00 +0.43% 72,809
2026-11-13 5,300.00 5,300.50 5,103.50 5,114.00 -3.55% 407,161
2026-11-12 5,422.00 5,422.00 5,173.00 5,302.00 -2.68% 1,000,355
2026-11-11 5,400.00 5,448.00 5,277.00 5,448.00 +0.92% 148,507
2026-11-09 5,319.00 5,475.00 5,312.50 5,398.50 +1.78% 169,880
2026-11-06 5,186.50 5,297.00 5,141.00 5,297.00 +2.06% 65,881
2026-11-05 5,234.50 5,234.50 5,151.50 5,190.00 -0.51% 92,864
2026-11-04 5,230.00 5,230.00 5,141.00 5,216.50 -0.37% 48,616
2026-11-03 5,111.00 5,252.00 5,107.00 5,236.00 +1.57% 129,407
2026-11-02 5,100.00 5,155.00 5,044.00 5,155.00 +0.81% 100,190
2026-10-30 5,060.50 5,134.50 5,030.00 5,113.50 +0.68% 108,036
2026-10-29 5,093.00 5,104.00 5,045.00 5,079.00 +0.18% 58,530
2026-10-28 5,076.00 5,079.00 5,003.50 5,070.00 -0.16% 78,885
2026-10-27 4,990.00 5,166.00 4,963.00 5,078.00 +0.95% 166,281
2026-10-26 4,960.00 5,030.00 4,878.50 5,030.00 +1.68% 69,617
2026-10-23 4,975.50 5,019.50 4,877.00 4,947.00 -1.33% 54,982
2026-10-22 4,982.00 5,015.00 4,811.00 5,013.50 -0.03% 49,335
2026-10-21 4,979.00 5,050.50 4,891.50 5,015.00 +0.22% 279,107
2026-10-19 5,042.50 5,099.50 4,975.50 5,004.00 -0.91% 95,218
2026-10-16 5,138.50 5,147.00 5,042.00 5,050.00 -1.38% 160,798
2026-10-15 5,210.00 5,249.00 5,120.50 5,120.50 -1.55% 59,913
2026-10-14 5,259.00 5,270.50 5,171.00 5,201.00 -0.93% 79,840
2026-10-13 5,206.00 5,288.50 5,172.00 5,250.00 +0.86% 103,084
2026-10-12 5,256.50 5,300.50 5,201.00 5,205.00 -1.40% 179,595
2026-10-09 5,252.00 5,299.00 5,225.00 5,279.00 +0.56% 96,074
2026-10-08 5,407.00 5,407.00 5,237.50 5,249.50 -1.89% 281,234
2026-10-07 5,297.00 5,404.50 5,292.00 5,350.50 +1.11% 205,152
2026-10-06 5,223.50 5,292.00 5,165.00 5,292.00 +1.92% 63,668
2026-10-05 5,210.00 5,235.00 5,136.00 5,192.50 -0.53% 102,619
2026-10-01 5,150.00 5,220.00 5,110.00 5,220.00 +1.09% 291,015
2026-09-30 5,249.50 5,276.50 5,135.00 5,163.50 -1.65% 146,577
2026-09-29 5,166.50 5,306.50 5,152.00 5,250.00 +1.45% 244,410
2026-09-28 5,254.00 5,273.50 5,131.00 5,175.00 -1.88% 101,714
2026-09-25 5,322.50 5,325.00 5,237.00 5,274.00 -0.98% 28,742
2026-09-24 5,372.00 5,447.00 5,261.50 5,326.00 -1.69% 165,474
2026-09-23 5,344.00 5,445.00 5,316.00 5,417.50 +1.61% 140,012
2026-09-22 5,365.00 5,419.50 5,308.50 5,331.50 -0.61% 94,905
2026-09-21 5,395.00 5,411.00 5,316.50 5,364.00 -1.88% 94,968
2026-09-18 5,378.50 5,466.50 5,310.50 5,466.50 +2.21% 320,770
2026-09-17 5,175.00 5,361.00 5,161.50 5,348.50 +3.35% 231,871
2026-09-16 5,170.50 5,265.50 5,148.00 5,175.00 +0.27% 304,188
2026-09-15 5,170.00 5,290.00 5,140.50 5,161.00 +1.44% 253,213
2026-09-11 5,122.00 5,128.00 5,051.00 5,087.50 -0.98% 238,760
2026-09-10 5,166.00 5,185.00 5,104.50 5,138.00 -0.02% 41,390
2026-09-09 5,181.00 5,222.00 5,139.00 5,139.00 -0.81% 106,076
2026-09-08 5,172.50 5,206.50 5,129.50 5,181.00 -1.17% 75,997
2026-09-07 5,219.00 5,242.50 5,104.50 5,242.50 +1.01% 139,659
2026-09-04 5,190.00 5,210.50 5,130.00 5,190.00 -0.06% 63,261
2026-09-03 5,210.00 5,233.50 5,157.00 5,193.00 -0.33% 95,991
2026-09-02 5,280.00 5,289.50 5,187.50 5,210.00 -1.70% 218,220
2026-09-01 5,329.50 5,358.00 5,277.00 5,300.00 -0.55% 88,288
2026-08-31 5,355.00 5,378.50 5,297.00 5,329.50 -0.48% 120,023
2026-08-28 5,352.50 5,406.50 5,316.00 5,355.00 +0.66% 231,100
2026-08-27 5,323.50 5,358.50 5,297.50 5,320.00 +0.31% 166,838
2026-08-26 5,368.00 5,387.50 5,303.50 5,303.50 -1.20% 44,001
2026-08-25 5,378.00 5,378.00 5,297.00 5,368.00 +0.34% 48,065
2026-08-24 5,400.00 5,400.00 5,315.00 5,350.00 -0.93% 46,339
2026-08-21 5,400.00 5,454.00 5,340.00 5,400.00 +0.00% 76,854
2026-08-20 5,400.00 5,416.50 5,381.50 5,400.00 +0.33% 85,369
2026-08-19 5,475.00 5,489.50 5,370.00 5,382.50 -1.69% 213,076
2026-08-18 5,374.00 5,510.00 5,374.00 5,475.00 +1.88% 127,028
2026-08-17 5,379.50 5,483.00 5,312.00 5,374.00 +0.11% 153,275
2026-08-14 5,432.00 5,448.00 5,175.00 5,368.00 -1.50% 635,598
2026-08-13 5,459.00 5,483.00 5,406.00 5,449.50 -0.56% 33,025
2026-08-12 5,518.00 5,534.50 5,411.50 5,480.00 -0.86% 110,443
2026-08-11 5,590.00 5,590.00 5,475.00 5,527.50 -1.27% 115,598
2026-08-10 5,624.00 5,700.00 5,528.50 5,598.50 -0.38% 82,544
2026-08-07 5,520.50 5,647.50 5,506.00 5,620.00 +0.40% 76,165
2026-08-06 5,692.00 5,695.50 5,586.00 5,597.50 -1.74% 109,477
2026-08-05 5,620.50 5,696.50 5,556.00 5,696.50 +1.58% 88,646
2026-08-04 5,699.00 5,710.00 5,608.00 5,608.00 -1.73% 37,653
2026-08-03 5,774.50 5,774.50 5,668.00 5,707.00 -0.77% 122,664
2026-07-31 5,825.00 5,833.00 5,735.00 5,751.50 -1.12% 116,595
2026-07-30 5,689.00 5,882.50 5,680.00 5,816.50 +2.54% 301,501
2026-07-29 5,699.00 5,711.50 5,654.00 5,672.50 +0.37% 57,547
2026-07-28 5,613.00 5,661.50 5,585.00 5,651.50 +0.69% 58,815
2026-07-27 5,693.50 5,699.50 5,597.00 5,613.00 -0.36% 112,113
2026-07-24 5,561.50 5,644.50 5,561.50 5,633.50 +0.56% 55,151
2026-07-23 5,601.00 5,637.00 5,511.50 5,602.00 +0.30% 50,659
2026-07-22 5,680.50 5,680.50 5,503.00 5,585.00 -1.70% 109,986
2026-07-21 5,690.00 5,695.00 5,623.50 5,681.50 +0.50% 27,882
2026-07-20 5,595.00 5,689.00 5,564.00 5,653.50 +1.63% 108,861
2026-07-17 5,709.00 5,709.00 5,539.00 5,563.00 -2.56% 70,604
2026-07-16 5,659.50 5,735.50 5,642.50 5,709.00 +0.88% 67,610
2026-07-15 5,645.00 5,706.50 5,574.00 5,659.00 +1.03% 213,207
2026-07-14 5,546.50 5,665.00 5,515.50 5,601.50 +0.62% 521,134
2026-07-13 5,615.50 5,684.00 5,548.50 5,567.00 -1.81% 219,164
2026-07-10 5,699.00 5,727.50 5,635.00 5,669.50 +0.37% 104,124
2026-07-09 5,634.00 5,695.00 5,602.50 5,648.50 +0.76% 39,730
2026-07-08 5,679.50 5,729.50 5,562.50 5,606.00 -1.09% 101,198
2026-07-07 5,635.00 5,735.00 5,608.00 5,667.50 +1.23% 200,471
2026-07-06 5,600.00 5,633.00 5,531.50 5,598.50 +0.65% 99,065
2026-07-03 5,510.50 5,631.00 5,494.00 5,562.50 +1.13% 568,290
2026-07-02 5,545.00 5,576.00 5,487.00 5,500.50 -1.20% 163,412
2026-07-01 5,594.00 5,639.00 5,514.00 5,567.50 -0.04% 128,296
2026-06-30 5,416.50 5,608.00 5,416.50 5,570.00 +2.83% 340,712
2026-06-29 5,429.00 5,530.00 5,394.50 5,416.50 -0.16% 193,434
2026-06-25 5,486.00 5,490.00 5,408.50 5,425.00 -0.06% 146,158
2026-06-24 5,460.00 5,490.50 5,416.50 5,428.50 +0.24% 124,021
2026-06-23 5,436.00 5,511.00 5,394.00 5,415.50 +0.90% 210,575
2026-06-22 5,394.00 5,398.00 5,336.00 5,367.00 -0.12% 106,481
2026-06-19 5,350.00 5,405.00 5,333.00 5,373.50 +0.03% 82,881
2026-06-18 5,379.50 5,388.00 5,321.00 5,372.00 +0.46% 75,504
2026-06-17 5,347.50 5,367.00 5,332.50 5,347.50 -0.01% 65,106
2026-06-16 5,350.00 5,372.50 5,312.50 5,348.00 +0.26% 83,189
2026-06-15 5,320.00 5,362.00 5,305.00 5,334.00 +0.68% 70,006
2026-06-12 5,340.00 5,358.50 5,283.00 5,298.00 -0.07% 67,310
2026-06-11 5,324.00 5,334.50 5,262.00 5,301.50 +0.04% 120,184
2026-06-10 5,355.00 5,470.00 5,286.00 5,299.50 -1.05% 117,951
2026-06-09 5,405.00 5,407.00 5,318.50 5,355.50 -0.02% 177,273
2026-06-08 5,250.00 5,399.00 5,175.50 5,356.50 +2.00% 225,217
2026-06-05 5,299.50 5,338.50 5,222.50 5,251.50 -0.47% 143,792
2026-06-04 5,274.00 5,339.00 5,213.50 5,276.50 +0.05% 150,489
2026-06-03 5,255.00 5,297.00 5,162.50 5,274.00 +0.67% 167,288
2026-06-02 5,272.50 5,449.00 5,223.50 5,239.00 -1.42% 216,729
2026-06-01 5,443.50 5,474.00 5,280.00 5,314.50 -3.34% 215,846
2026-05-29 5,578.00 5,789.00 5,472.00 5,498.00 +0.85% 1,404,988
2026-05-27 5,414.50 5,521.50 5,329.00 5,451.50 +1.33% 186,374
2026-05-26 5,405.00 5,422.00 5,336.00 5,380.00 -0.38% 63,451
2026-05-25 5,485.00 5,485.00 5,388.50 5,400.50 -0.07% 41,636
2026-05-22 5,530.00 5,530.00 5,385.00 5,404.50 -1.76% 64,842
2026-05-21 5,465.00 5,604.00 5,416.00 5,501.50 +1.20% 100,493
2026-05-20 5,437.50 5,507.50 5,416.50 5,436.50 -0.61% 50,467
2026-05-19 5,465.00 5,605.50 5,445.50 5,470.00 +0.04% 105,741
2026-05-18 5,465.00 5,525.00 5,390.00 5,468.00 -0.33% 122,385

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 17 Nov 2026. Latest filing is for the expected quarter (Sep 2026). Company: Alkem Laboratories Limited, ISIN INE540L01014.

Promoters and group
49.70%
0.00 pp vs Jun 2026
Public (all, Category B)
50.30%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group49.70%49.70%0.00 pp--1.50 ppNo material change.
Public (all, Category B)50.30%50.30%0.00 pp-+1.50 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The filing file for Sep 2026 is not loaded yet. An admin can load it.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202649.70%0.00 pp50.30%0.00 pp17 Nov 2026
Jun 202649.70%-1.50 pp50.30%+1.50 pp09 Jul 2026
Mar 202651.20%0.00 pp48.80%0.00 pp15 Apr 2026
Dec 202551.20%0.00 pp48.80%0.00 pp13 Jan 2026
Sep 202551.20%-1.84 pp48.80%+1.84 pp15 Oct 2025
Jun 202553.04%-2.09 pp46.96%+2.09 pp21 Jul 2025
Mar 202555.13%-0.53 pp44.87%+0.53 pp17 Apr 2025NSE
Dec 202455.66%0.00 pp44.34%0.00 pp16 Jan 2025NSE
Sep 202455.66%-0.72 pp44.34%+0.72 pp16 Oct 2024NSE
Jun 202456.38%-0.36 pp43.62%+0.36 pp12 Jul 2024NSE
Mar 202456.74%0.00 pp43.26%0.00 pp18 Apr 2024NSE
Dec 202356.74%0.00 pp43.26%0.00 pp15 Jan 2024NSE
Sep 202356.74%-0.42 pp43.26%+0.42 pp06 Oct 2023NSE
Jun 202357.16%0.00 pp42.84%0.00 pp17 Jul 2023NSE
Mar 202357.16%0.00 pp42.84%0.00 pp14 Apr 2023NSE
Dec 202257.16%0.00 pp42.84%0.00 pp16 Jan 2023NSE
Sep 202257.16%+0.02 pp42.84%-0.02 pp20 Oct 2022NSE
Jun 2022 revised57.14%+0.01 pp42.86%-0.01 pp20 Jul 2022NSE
Mar 202257.13%0.00 pp42.87%0.00 pp20 Apr 2022NSE
Dec 202157.13%-1.71 pp42.87%+1.71 pp19 Jan 2022NSE
Sep 202158.84%-41.16%-11 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.